Compare Enzyme (MLN) vs Sologenic (SOLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Sologenic — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Sologenic trades at Rp751.86 (market cap Rp312,64M, Rp1,6M 24h volume). The key difference: Sologenic is far larger — about 2.3× Enzyme's market cap, and Sologenic's supply is capped (398,8M / 400M SOLO (100%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Sologenic for 21 Days on average.
| MLN | SOLO | |
|---|---|---|
Market Cap | Rp134,13M | Rp312,64M |
Volume (24h) | Rp104,56M | Rp1,6M |
Circulating Supply | 3,3M MLN | 398,8M / 400M SOLO (100%) |
Typical Hold Time | 28 Days | 21 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Sologenic (SOLO) currently trades with a market cap of Rp312.64 million and near-full circulating supply of 398.8 million tokens. The asset shows limited trading activity with a 21-day average hold time indicating reduced volatility. Recent ecosystem developments focus on token utility expansion through blockchain integrations and DeFi partnerships, though specific price data is unavailable in the current snapshot.
Outlook remains cautious due to thin liquidity and minimal market presence. Key opportunities include potential protocol upgrades and expanding utility, while major risks involve low exchange liquidity, regulatory uncertainty for crypto assets in Indonesia, and vulnerability to market manipulation given the small market cap.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Sologenic
Sologenic is reshaping the asset trading landscape by integrating tokenized securities, crypto assets, and NFTs. The ecosystem is supported by two distinct teams: Sologenic.org (the SOLO Core Team), which focuses on expanding Sologenic as a decentralized ecosystem, and Sologenic.com, which is dedicated to launching key use cases such as securities tokenization. This dual approach ensures both the growth of the ecosystem and practical utility for users.
Read more on SOLO →
